25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

AZNCF (Astrazeneca) Stock Analysis
Buy, Hold or Sell?

Let's analyze Astrazeneca together

I guess you are interested in AstraZeneca PLC. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • ๐Ÿ“Š Fundamental Analysis (FA) โ€“ Astrazenecaโ€™s Financial Insights
  • ๐Ÿ“ˆ Technical Analysis (TA) โ€“ Astrazenecaโ€™s Price Targets

I'm going to help you getting a better view of AstraZeneca PLC. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about AstraZeneca PLC

I send you an email if I find something interesting about AstraZeneca PLC.

1. Quick Overview

1.1. Quick analysis of Astrazeneca (30 sec.)










1.2. What can you expect buying and holding a share of Astrazeneca? (30 sec.)

How much money do you get?

How much money do you get?
$3.22
When do you have the money?
1 year
How often do you get paid?
95.0%

What is your share worth?

Current worth
$28.74
Expected worth in 1 year
$32.10
How sure are you?
87.5%

+ What do you gain per year?

Total Gains per Share
$6.57
Return On Investment
4.2%

For what price can you sell your share?

Current Price per Share
$155.00
Expected price per share
$141.77 - $171.24
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Astrazeneca (5 min.)




Live pricePrice per Share (EOD)
$155.00
Intrinsic Value Per Share
$28.04 - $69.16
Total Value Per Share
$56.79 - $97.90

2.2. Growth of Astrazeneca (5 min.)




Is Astrazeneca growing?

Current yearPrevious yearGrowGrow %
How rich?$44.8b$38.3b$3.5b8.5%

How much money is Astrazeneca making?

Current yearPrevious yearGrowGrow %
Making money$2b$1.6b$482.3m23.1%
Net Profit Margin14.9%13.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Astrazeneca (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Astrazeneca?

Welcome investor! Astrazeneca's management wants to use your money to grow the business. In return you get a share of Astrazeneca.

First you should know what it really means to hold a share of Astrazeneca. And how you can make/lose money.

Speculation

The Price per Share of Astrazeneca is $155.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Astrazeneca.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Astrazeneca, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $28.74. Based on the TTM, the Book Value Change Per Share is $0.84 per quarter. Based on the YOY, the Book Value Change Per Share is $0.35 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.80 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Astrazeneca.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps1.571.0%1.340.9%1.030.7%1.120.7%0.750.5%0.580.4%
Usd Book Value Change Per Share2.381.5%0.840.5%0.350.2%0.470.3%1.000.6%0.420.3%
Usd Dividend Per Share0.010.0%0.800.5%0.710.5%0.740.5%0.790.5%0.910.6%
Usd Total Gains Per Share2.381.5%1.641.1%1.060.7%1.220.8%1.781.2%1.330.9%
Usd Price Per Share138.18-142.50-140.68-138.34-129.71-99.92-
Price to Earnings Ratio21.98-29.32-37.28-34.33-37.24--144.15-
Price-to-Total Gains Ratio57.94-787.70-139.37-365.50-147.49-301.81-
Price to Book Ratio4.81-5.32-5.72-5.56-6.64-7.06-
Price-to-Total Gains Ratio57.94-787.70-139.37-365.50-147.49-301.81-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share155
Number of shares6
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.800.79
Usd Book Value Change Per Share0.841.00
Usd Total Gains Per Share1.641.78
Gains per Quarter (6 shares)9.8610.71
Gains per Year (6 shares)39.4342.83
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1192029192433
2394068384876
358601075772119
477811467696162
59610118595120205
6116121224113144248
7135141263132167291
8154161302151191334
9174181341170215377
10193201380189239420

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%18.02.00.090.0%37.03.00.092.5%98.06.00.094.2%
Book Value Change Per Share4.00.00.0100.0%8.04.00.066.7%11.09.00.055.0%20.020.00.050.0%57.047.00.054.8%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%38.00.02.095.0%74.00.030.071.2%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%17.03.00.085.0%35.05.00.087.5%88.016.00.084.6%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of AstraZeneca PLC compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--2.3780.839+184%0.351+578%0.475+401%0.997+139%0.423+462%
Book Value Per Share--28.74326.849+7%24.581+17%24.915+15%21.736+32%15.697+83%
Current Ratio--0.8630.905-5%0.845+2%0.870-1%0.935-8%0.894-3%
Debt To Asset Ratio--0.6010.608-1%0.620-3%0.616-2%0.652-8%0.704-15%
Debt To Equity Ratio--1.5121.556-3%1.634-7%1.610-6%2.038-26%2.782-46%
Dividend Per Share--0.0060.804-99%0.706-99%0.745-99%0.788-99%0.908-99%
Enterprise Value--154918620000.000163203848750.000-5%163480994570.750-5%159527237773.583-3%148062270691.464+5%111458873054.882+39%
Eps--1.5721.341+17%1.032+52%1.120+40%0.753+109%0.584+169%
Ev To Ebitda Ratio--7.8168.894-12%11.662-33%11.011-29%13.648-43%12.021-35%
Ev To Sales Ratio--2.6792.903-8%3.308-19%3.207-16%3.398-21%3.251-18%
Free Cash Flow Per Share--0.9381.422-34%1.166-20%1.213-23%1.040-10%0.627+50%
Free Cash Flow To Equity Per Share--1.2710.302+320%0.811+57%0.436+191%0.499+154%0.259+391%
Gross Profit Margin--0.9420.925+2%-3.699+493%-1.052+212%-1.424+251%23.654-96%
Intrinsic Value_10Y_max--69.156----------
Intrinsic Value_10Y_min--28.044----------
Intrinsic Value_1Y_max--5.160----------
Intrinsic Value_1Y_min--2.575----------
Intrinsic Value_3Y_max--16.854----------
Intrinsic Value_3Y_min--7.986----------
Intrinsic Value_5Y_max--30.173----------
Intrinsic Value_5Y_min--13.630----------
Market Cap240288747520.000+10%215422620000.000222444525000.000-3%219497337500.000-2%215853077500.0000%202050324527.314+7%155378128146.435+39%
Net Profit Margin--0.1690.149+14%0.130+31%0.139+22%0.103+65%0.107+58%
Operating Margin--0.2470.208+19%0.188+31%0.184+34%0.146+69%0.162+52%
Operating Ratio--0.7570.799-5%0.832-9%0.822-8%0.855-11%0.843-10%
Pb Ratio5.393+11%4.8075.319-10%5.721-16%5.562-14%6.637-28%7.060-32%
Pe Ratio24.658+11%21.98229.316-25%37.282-41%34.330-36%37.238-41%-144.148+756%
Price Per Share155.000+11%138.180142.500-3%140.682-2%138.3420%129.710+7%99.916+38%
Price To Free Cash Flow Ratio41.293+11%36.81227.334+35%34.192+8%31.346+17%37.890-3%35.931+2%
Price To Total Gains Ratio64.996+11%57.943787.703-93%139.370-58%365.499-84%147.488-61%301.808-81%
Quick Ratio--0.6360.667-5%0.611+4%0.643-1%0.673-5%0.672-5%
Return On Assets--0.0220.019+12%0.016+37%0.017+27%0.013+73%0.012+87%
Return On Equity--0.0550.050+10%0.042+30%0.045+22%0.038+42%0.043+26%
Total Gains Per Share--2.3851.643+45%1.057+126%1.220+96%1.785+34%1.332+79%
Usd Book Value--44810000000.00041910224750.000+7%38352190335.000+17%38874055028.333+15%33869633017.000+32%24420691508.500+83%
Usd Book Value Change Per Share--2.3780.839+184%0.351+578%0.475+401%0.997+139%0.423+462%
Usd Book Value Per Share--28.74326.849+7%24.581+17%24.915+15%21.736+32%15.697+83%
Usd Dividend Per Share--0.0060.804-99%0.706-99%0.745-99%0.788-99%0.908-99%
Usd Enterprise Value--154918620000.000163203848750.000-5%163480994570.750-5%159527237773.583-3%148062270691.464+5%111458873054.882+39%
Usd Eps--1.5721.341+17%1.032+52%1.120+40%0.753+109%0.584+169%
Usd Free Cash Flow--1463000000.0002219160892.000-34%1819363177.000-20%1892924689.667-23%1620954813.800-10%975927406.900+50%
Usd Free Cash Flow Per Share--0.9381.422-34%1.166-20%1.213-23%1.040-10%0.627+50%
Usd Free Cash Flow To Equity Per Share--1.2710.302+320%0.811+57%0.436+191%0.499+154%0.259+391%
Usd Market Cap240288747520.000+10%215422620000.000222444525000.000-3%219497337500.000-2%215853077500.0000%202050324527.314+7%155378128146.435+39%
Usd Price Per Share155.000+11%138.180142.500-3%140.682-2%138.3420%129.710+7%99.916+38%
Usd Profit--2450000000.0002092381500.750+17%1610000000.000+52%1747627166.917+40%1174476300.150+109%914838150.075+168%
Usd Revenue--14457000000.00014125250000.000+2%12354200817.250+17%12533483605.750+15%11198390163.450+29%8522045081.725+70%
Usd Total Gains Per Share--2.3851.643+45%1.057+126%1.220+96%1.785+34%1.332+79%
 EOD+4 -4MRQTTM+24 -16YOY+26 -143Y+24 -165Y+29 -1110Y+29 -11

3.3 Fundamental Score

Let's check the fundamental score of AstraZeneca PLC based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1524.658
Price to Book Ratio (EOD)Between0-15.393
Net Profit Margin (MRQ)Greater than00.169
Operating Margin (MRQ)Greater than00.247
Quick Ratio (MRQ)Greater than10.636
Current Ratio (MRQ)Greater than10.863
Debt to Asset Ratio (MRQ)Less than10.601
Debt to Equity Ratio (MRQ)Less than11.512
Return on Equity (MRQ)Greater than0.150.055
Return on Assets (MRQ)Greater than0.050.022
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of AstraZeneca PLC based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose155.000
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About AstraZeneca PLC

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Crestor, Seloken, Lokelma, Roxadustat, Andexxa, Wainua, Symbicort, Fasenra, Pulmicort, Breztri/Trixeo, Saphnelo, Tezspire, Airsupra, Ultomiris, Soliris, Strensiq, Koselugo, Kanuma, Atacand, Plendil, Modip, Splendil, Munobal, Flodil, Komboglyze, Qtern, Byetta, XIGDUO, Accolate, Accoleit, Vanticon, Beyfortus, Synagis, FluMist, tixagevimab and cilgavimab, and sipavibart. It also provides Bricanyl Respules, Eklira Genuair/Tudorza/Bretaris, Bricanyl Turbuhaler, Rhinocort, Bevespi Aerosphere, Daliresp/Daxas, Oxis Turbuhaler, Breztri Aerosphere, Duaklir Genuair, Kavigale, Evusheld, Fluenz/FluMist, and Voydeya. The company offers its products for ocology, cardiovascular, renal and metabolism, respiratory & immunology, vaccines and immune, and therapies rare diseases. It serves primary and specialty care physicians through distributors and local representative offices in the United Kingdom, the United States, Europe, and Asia. It has a strategic agreement with Tempus to develop the largest multimodal foundation model in oncology. The company has a collaboration agreement with IonQ, Inc. for the development of quantum-accelerated computational chemistry workflow for healthcare, life sciences, and chemistry; a strategic research collaboration with CSPC Pharmaceutical Group Limited to advance the discovery and development of novel oral candidates, with the potential to treat diseases across multiple indications; and collaboration Revna Biosciences for lung cancer treatment. AstraZeneca PLC was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

Fundamental data was last updated by Penke on 2025-09-11 19:32:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is underpriced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitย Astrazeneca earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareย Astrazeneca to theย Drug Manufacturers - General industry mean.
  • A Net Profit Margin of 16.9%ย means thatย $0.17 for each $1ย in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of AstraZeneca PLC:

  • The MRQ is 16.9%. The company is making a huge profit. +2
  • The TTM is 14.9%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ16.9%TTM14.9%+2.1%
TTM14.9%YOY13.0%+1.9%
TTM14.9%5Y10.3%+4.6%
5Y10.3%10Y10.7%-0.5%
4.3.1.2. Return on Assets

Shows howย efficientย Astrazeneca is using its assets to generate profit.

  • Above 5% is considered healthyย but always compareย Astrazeneca to theย Drug Manufacturers - General industry mean.
  • 2.2% Return on Assets means thatย Astrazeneca generatedย $0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of AstraZeneca PLC:

  • The MRQ is 2.2%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.9%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.2%TTM1.9%+0.2%
TTM1.9%YOY1.6%+0.4%
TTM1.9%5Y1.3%+0.7%
5Y1.3%10Y1.2%+0.1%
4.3.1.3. Return on Equity

Shows how efficient Astrazeneca is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareย Astrazeneca to theย Drug Manufacturers - General industry mean.
  • 5.5% Return on Equity means Astrazeneca generated $0.05ย for eachย $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of AstraZeneca PLC:

  • The MRQ is 5.5%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 5.0%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ5.5%TTM5.0%+0.5%
TTM5.0%YOY4.2%+0.8%
TTM5.0%5Y3.8%+1.1%
5Y3.8%10Y4.3%-0.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of AstraZeneca PLC.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measuresย how efficient Astrazeneca is operatingย .

  • Measures how much profit Astrazeneca makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareย Astrazeneca to theย Drug Manufacturers - General industry mean.
  • An Operating Margin of 24.7%ย means the company generated $0.25 ย for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of AstraZeneca PLC:

  • The MRQ is 24.7%. The company is operating efficient. +1
  • The TTM is 20.8%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ24.7%TTM20.8%+3.9%
TTM20.8%YOY18.8%+2.0%
TTM20.8%5Y14.6%+6.2%
5Y14.6%10Y16.2%-1.6%
4.3.2.2. Operating Ratio

Measures how efficient Astrazeneca is keepingย operating costsย low.

  • Below 1 is considered healthy (always compare toย Drug Manufacturers - General industry mean).
  • An Operation Ratio of 0.76 means that the operating costs are $0.76 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of AstraZeneca PLC:

  • The MRQ is 0.757. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.799. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.757TTM0.799-0.041
TTM0.799YOY0.832-0.033
TTM0.7995Y0.855-0.056
5Y0.85510Y0.843+0.012
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of AstraZeneca PLC.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Astrazeneca is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toย Drug Manufacturers - General industry mean).
  • A Current Ratio of 0.86ย means the company has $0.86 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of AstraZeneca PLC:

  • The MRQ is 0.863. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.905. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.863TTM0.905-0.042
TTM0.905YOY0.845+0.059
TTM0.9055Y0.935-0.030
5Y0.93510Y0.894+0.041
4.4.3.2. Quick Ratio

Measures if Astrazeneca is able to pay off Short-term Debt but only usingย theย most liquid assets.

  • Above 1 is considered healthy butย always compareย Astrazeneca to theย Drug Manufacturers - General industry mean.
  • A Quick Ratio of 0.64ย means the company can pay off $0.64 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of AstraZeneca PLC:

  • The MRQ is 0.636. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.667. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.636TTM0.667-0.031
TTM0.667YOY0.611+0.056
TTM0.6675Y0.673-0.006
5Y0.67310Y0.672+0.001
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of AstraZeneca PLC.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %ย of Astrazenecaย assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareย Astrazeneca to Drug Manufacturers - General industry mean.
  • A Debt to Asset Ratio of 0.60ย means that Astrazeneca assets areย financed with 60.1% credit (debt) and the remaining percentage (100% - 60.1%)ย is financed by its owners/shareholders.ย 

Let's take a look of the Debt to Asset Ratio trends of AstraZeneca PLC:

  • The MRQ is 0.601. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.608. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.601TTM0.608-0.007
TTM0.608YOY0.620-0.012
TTM0.6085Y0.652-0.044
5Y0.65210Y0.704-0.052
4.5.4.2. Debt to Equity Ratio

Measures ifย Astrazeneca is able toย pay off its debts by usingย shareholders equity.

  • Below 2 is considered healthy butย always compareย Astrazeneca to theย Drug Manufacturers - General industry mean.
  • A Debt to Equity ratio of 151.2% means that company has $1.51 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of AstraZeneca PLC:

  • The MRQ is 1.512. The company is just able to pay all its debts with equity.
  • The TTM is 1.556. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.512TTM1.556-0.044
TTM1.556YOY1.634-0.078
TTM1.5565Y2.038-0.482
5Y2.03810Y2.782-0.744
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measuresย how much money you payย for each share forย every $1 in earnings Astrazeneca generates.

  • Above 15 is considered overpriced butย always compareย Astrazeneca to theย Drug Manufacturers - General industry mean.
  • A PE ratio of 21.98 means the investor is paying $21.98ย for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of AstraZeneca PLC:

  • The EOD is 24.658. Based on the earnings, the company is fair priced.
  • The MRQ is 21.982. Based on the earnings, the company is fair priced.
  • The TTM is 29.316. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD24.658MRQ21.982+2.676
MRQ21.982TTM29.316-7.334
TTM29.316YOY37.282-7.966
TTM29.3165Y37.238-7.922
5Y37.23810Y-144.148+181.385
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of AstraZeneca PLC:

  • The EOD is 41.293. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 36.812. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 27.334. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD41.293MRQ36.812+4.481
MRQ36.812TTM27.334+9.477
TTM27.334YOY34.192-6.857
TTM27.3345Y37.890-10.555
5Y37.89010Y35.931+1.958
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofย Astrazeneca is to cheap or to expensiveย compared to its book value.

  • At or below 1 is considered healthyย (always compare to Drug Manufacturers - General industry mean).
  • A PB ratio of 4.81 means the investor is paying $4.81ย for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of AstraZeneca PLC:

  • The EOD is 5.393. Based on the equity, the company is overpriced. -1
  • The MRQ is 4.807. Based on the equity, the company is fair priced.
  • The TTM is 5.319. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD5.393MRQ4.807+0.585
MRQ4.807TTM5.319-0.512
TTM5.319YOY5.721-0.401
TTM5.3195Y6.637-1.318
5Y6.63710Y7.060-0.423
4.6.2. Total Gains per Share

2.4. Latest News of AstraZeneca PLC

Does AstraZeneca PLC still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from AstraZeneca PLC to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-09-12
22:48
AstraZeneca pauses ยฃ200m expansion in CambridgeRead
2025-09-12
21:46
Sector Update: Health Care Stocks Fall Late AfternoonRead
2025-09-12
20:05
AstraZeneca pauses ยฃ200m Cambridge expansion amid NHS pricing rowRead
2025-09-12
19:40
AstraZeneca (LSE:AZN) Advances Cancer Drug In EU With EMA Application ValidationRead
2025-09-12
18:38
AstraZeneca pauses $270 million investment in BritainRead
2025-09-12
18:11
Novartis Catches a โ€˜Sell.โ€™ Goldman Sachs Says the Stock Is Overvalued.Read
2025-09-12
08:37
UK's September 2025 Stock Selections Estimated Below Intrinsic ValueRead
2025-09-12
07:01
AstraZeneca (AZN) Price Target Backed by Goldman After Baxdrostat Phase 3 DataRead
2025-09-11
22:16
Top Research Reports for Oracle, AstraZeneca & ShopifyRead
2025-09-11
08:47
Merck scraps ยฃ1bn London expansion as report warns UK drugs sector โ€˜losing outโ€™Read
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2025-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets112,422,000
Total Liabilities67,612,000
Total Stockholder Equity44,719,000
 As reported
Total Liabilities 67,612,000
Total Stockholder Equity+ 44,719,000
Total Assets = 112,422,000

Assets

Total Assets112,422,000
Total Current Assets28,939,000
Long-term Assets83,483,000
Total Current Assets
Cash And Cash Equivalents 7,058,000
Short-term Investments 50,000
Net Receivables 14,168,000
Inventory 6,467,000
Other Current Assets 1,196,000
Total Current Assets  (as reported)28,939,000
Total Current Assets  (calculated)28,939,000
+/-0
Long-term Assets
Property Plant Equipment 13,229,000
Goodwill 21,222,000
Intangible Assets 37,925,000
Long-term Assets  (as reported)83,483,000
Long-term Assets  (calculated)72,376,000
+/- 11,107,000

Liabilities & Shareholders' Equity

Total Current Liabilities33,536,000
Long-term Liabilities34,076,000
Total Stockholder Equity44,719,000
Total Current Liabilities
Short-term Debt 6,853,000
Short Long Term Debt 6,492,000
Accounts payable 23,986,000
Other Current Liabilities 1,268,000
Total Current Liabilities  (as reported)33,536,000
Total Current Liabilities  (calculated)38,599,000
+/- 5,063,000
Long-term Liabilities
Long term Debt 24,714,000
Capital Lease Obligations 1,633,000
Long-term Liabilities  (as reported)34,076,000
Long-term Liabilities  (calculated)26,347,000
+/- 7,729,000
Total Stockholder Equity
Common Stock388,000
Retained Earnings 7,023,000
Other Stockholders Equity 37,308,000
Total Stockholder Equity (as reported)44,719,000
Total Stockholder Equity (calculated)44,719,000
+/-0
Other
Capital Stock388,000
Cash and Short Term Investments 7,108,000
Common Stock Shares Outstanding 1,559,000
Liabilities and Stockholders Equity 112,422,000
Net Debt 25,781,000
Net Invested Capital 75,925,000
Net Working Capital -4,597,000
Property Plant and Equipment Gross 13,229,000
Short Long Term Debt Total 32,839,000



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-311996-12-311996-09-301996-06-301996-03-311995-12-311995-09-301995-06-301995-03-311994-12-311994-09-301994-06-301994-03-311993-12-311993-09-301993-06-301993-03-31
> Total Assets 
0
0
0
7,424,117
0
0
0
7,318,293
0
7,827,400
0
7,869,769
0
0
0
8,562,524
0
0
0
8,282,087
0
8,913,000
0
8,979,998
0
19,630,000
20,576,000
19,806,259
18,410,250
19,960,587
20,409,618
18,446,051
19,071,996
18,429,173
19,105,057
26,445,036
19,989,948
20,319,182
20,534,777
21,576,000
22,532,081
22,207,711
23,054,000
23,573,000
23,785,000
24,343,000
24,471,000
25,616,000
24,840,000
24,884,000
24,527,000
24,840,000
29,932,000
28,459,000
28,122,000
29,932,000
29,565,000
47,600,000
45,950,000
47,957,000
48,458,000
50,202,000
48,204,000
46,784,000
46,515,000
50,200,000
51,899,000
54,920,000
54,075,000
54,647,000
56,390,000
56,127,000
54,534,000
53,406,000
52,576,000
52,830,000
50,763,000
51,390,000
52,448,000
53,534,000
52,329,000
53,987,000
54,121,000
55,899,000
59,390,000
58,539,000
56,164,000
58,595,000
53,701,000
55,169,000
54,118,000
60,124,000
64,323,000
64,419,000
63,222,000
62,526,000
60,959,000
65,119,000
64,587,000
63,354,000
63,281,000
61,344,000
61,443,000
60,651,000
61,055,000
61,889,000
58,906,000
61,377,000
57,211,000
59,929,000
64,112,000
66,729,000
64,926,000
73,641,000
107,221,000
105,363,000
100,273,000
96,579,000
94,185,000
96,483,000
96,687,000
96,543,000
96,086,000
100,976,221
102,216,073
104,356,508
104,922,000
104,035,000
106,314,739
112,422,000
112,422,000106,314,739104,035,000104,922,000104,356,508102,216,073100,976,22196,086,00096,543,00096,687,00096,483,00094,185,00096,579,000100,273,000105,363,000107,221,00073,641,00064,926,00066,729,00064,112,00059,929,00057,211,00061,377,00058,906,00061,889,00061,055,00060,651,00061,443,00061,344,00063,281,00063,354,00064,587,00065,119,00060,959,00062,526,00063,222,00064,419,00064,323,00060,124,00054,118,00055,169,00053,701,00058,595,00056,164,00058,539,00059,390,00055,899,00054,121,00053,987,00052,329,00053,534,00052,448,00051,390,00050,763,00052,830,00052,576,00053,406,00054,534,00056,127,00056,390,00054,647,00054,075,00054,920,00051,899,00050,200,00046,515,00046,784,00048,204,00050,202,00048,458,00047,957,00045,950,00047,600,00029,565,00029,932,00028,122,00028,459,00029,932,00024,840,00024,527,00024,884,00024,840,00025,616,00024,471,00024,343,00023,785,00023,573,00023,054,00022,207,71122,532,08121,576,00020,534,77720,319,18219,989,94826,445,03619,105,05718,429,17319,071,99618,446,05120,409,61819,960,58718,410,25019,806,25920,576,00019,630,00008,979,99808,913,00008,282,0870008,562,5240007,869,76907,827,40007,318,2930007,424,117000
   > Total Current Assets 
0
0
0
4,894,681
0
0
0
4,547,942
0
4,842,500
0
4,864,330
0
0
0
5,197,452
0
0
0
4,721,285
0
4,711,000
0
4,463,441
0
9,757,000
10,459,000
9,909,127
10,501,453
10,254,329
11,145,586
10,520,970
11,446,786
10,771,003
11,159,814
14,820,503
11,772,225
11,419,734
11,531,604
12,126,000
12,950,313
12,265,081
12,996,000
12,933,000
13,261,000
11,911,000
12,253,000
14,440,000
13,770,000
13,438,000
13,095,000
13,770,000
16,936,000
15,051,000
14,433,000
16,936,000
16,286,000
16,078,000
14,691,000
17,082,000
14,452,000
16,476,000
15,570,000
16,152,000
15,852,000
19,126,000
20,540,000
23,760,000
22,347,000
23,376,000
24,569,000
25,131,000
23,467,000
22,691,000
22,467,000
23,506,000
21,560,000
19,777,000
18,029,000
19,048,000
18,344,000
19,394,000
18,792,000
20,335,000
16,542,000
16,204,000
15,072,000
16,697,000
12,691,000
13,812,000
13,199,000
16,007,000
12,769,000
13,320,000
12,866,000
13,262,000
11,637,000
14,298,000
13,634,000
13,150,000
13,182,000
12,449,000
13,108,000
15,591,000
13,649,000
15,219,000
13,520,000
15,563,000
12,822,000
14,930,000
18,166,000
19,544,000
18,735,000
27,274,000
26,691,000
26,244,000
22,647,000
20,917,000
20,224,000
22,593,000
22,266,000
22,839,000
22,501,000
25,018,624
25,574,753
25,397,018
24,155,000
25,827,000
26,154,188
28,939,000
28,939,00026,154,18825,827,00024,155,00025,397,01825,574,75325,018,62422,501,00022,839,00022,266,00022,593,00020,224,00020,917,00022,647,00026,244,00026,691,00027,274,00018,735,00019,544,00018,166,00014,930,00012,822,00015,563,00013,520,00015,219,00013,649,00015,591,00013,108,00012,449,00013,182,00013,150,00013,634,00014,298,00011,637,00013,262,00012,866,00013,320,00012,769,00016,007,00013,199,00013,812,00012,691,00016,697,00015,072,00016,204,00016,542,00020,335,00018,792,00019,394,00018,344,00019,048,00018,029,00019,777,00021,560,00023,506,00022,467,00022,691,00023,467,00025,131,00024,569,00023,376,00022,347,00023,760,00020,540,00019,126,00015,852,00016,152,00015,570,00016,476,00014,452,00017,082,00014,691,00016,078,00016,286,00016,936,00014,433,00015,051,00016,936,00013,770,00013,095,00013,438,00013,770,00014,440,00012,253,00011,911,00013,261,00012,933,00012,996,00012,265,08112,950,31312,126,00011,531,60411,419,73411,772,22514,820,50311,159,81410,771,00311,446,78610,520,97011,145,58610,254,32910,501,4539,909,12710,459,0009,757,00004,463,44104,711,00004,721,2850005,197,4520004,864,33004,842,50004,547,9420004,894,681000
       Cash And Cash Equivalents 
0
0
0
1,351,991
0
0
0
856,745
0
961,500
0
251,870
0
0
0
443,539
0
0
0
500,893
0
327,000
0
341,937
0
2,015,000
3,791,000
428,789
0
2,953,383
0
1,021,627
0
4,264,277
0
1,007,944
0
4,271,212
0
726,000
0
3,998,110
0
733,000
814,000
1,499,000
1,020,000
1,055,000
4,979,000
5,451,000
4,400,000
545,000
7,103,000
6,076,000
5,756,000
7,103,000
5,567,000
4,951,000
3,428,000
5,867,000
2,920,000
4,340,000
3,541,000
4,286,000
4,441,000
7,195,000
7,794,000
9,918,000
7,366,000
9,088,000
10,010,000
11,068,000
9,582,000
9,613,000
9,860,000
7,571,000
6,332,000
7,641,000
6,017,000
7,701,000
7,234,000
8,252,000
7,453,000
9,217,000
4,379,000
4,958,000
5,146,000
6,360,000
3,192,000
3,967,000
4,081,000
6,240,000
3,428,000
3,915,000
3,090,000
5,018,000
3,129,000
5,239,000
4,036,000
3,324,000
3,005,000
2,978,000
3,420,000
4,831,000
4,136,000
5,428,000
3,967,000
5,369,000
3,413,000
5,673,000
8,072,000
7,832,000
7,636,000
15,567,000
7,067,000
6,329,000
5,762,000
4,817,000
4,458,000
6,166,000
6,232,000
5,664,000
4,871,000
5,831,754
7,835,103
6,917,094
4,797,000
5,488,000
5,233,039
7,058,000
7,058,0005,233,0395,488,0004,797,0006,917,0947,835,1035,831,7544,871,0005,664,0006,232,0006,166,0004,458,0004,817,0005,762,0006,329,0007,067,00015,567,0007,636,0007,832,0008,072,0005,673,0003,413,0005,369,0003,967,0005,428,0004,136,0004,831,0003,420,0002,978,0003,005,0003,324,0004,036,0005,239,0003,129,0005,018,0003,090,0003,915,0003,428,0006,240,0004,081,0003,967,0003,192,0006,360,0005,146,0004,958,0004,379,0009,217,0007,453,0008,252,0007,234,0007,701,0006,017,0007,641,0006,332,0007,571,0009,860,0009,613,0009,582,00011,068,00010,010,0009,088,0007,366,0009,918,0007,794,0007,195,0004,441,0004,286,0003,541,0004,340,0002,920,0005,867,0003,428,0004,951,0005,567,0007,103,0005,756,0006,076,0007,103,000545,0004,400,0005,451,0004,979,0001,055,0001,020,0001,499,000814,000733,00003,998,1100726,00004,271,21201,007,94404,264,27701,021,62702,953,3830428,7893,791,0002,015,0000341,9370327,0000500,893000443,539000251,8700961,5000856,7450001,351,991000
       Short-term Investments 
0
0
0
199,692
0
0
0
292,357
0
0
0
971,939
0
0
0
1,226,153
0
0
0
704,225
0
0
0
273,882
0
1,249,000
0
2,857,595
0
0
0
3,430,816
0
0
0
4,456,935
0
0
0
3,962,000
0
0
0
3,218,000
2,573,000
2,573,000
3,167,000
4,091,000
1,624,000
398,000
1,242,000
6,058,000
657,000
1,020,000
413,000
581,000
849,000
360,000
102,000
91,000
55,000
58,000
55,000
388,000
49,000
42,000
40,000
1,508,000
2,030,000
1,964,000
1,517,000
1,482,000
1,199,000
679,000
924,000
4,248,000
3,637,000
1,555,000
799,000
823,000
795,000
839,000
864,000
796,000
777,000
819,000
804,000
795,000
493,000
531,000
496,000
613,000
671,000
731,000
909,000
884,000
530,000
998,000
1,175,000
1,230,000
866,000
799,000
808,000
849,000
822,000
819,000
813,000
849,000
752,000
442,000
374,000
160,000
129,000
62,000
82,000
69,000
61,000
70,000
440,000
239,000
230,000
148,000
244,000
121,828
179,865
160,025
133,000
166,000
165,000
50,000
50,000165,000166,000133,000160,025179,865121,828244,000148,000230,000239,000440,00070,00061,00069,00082,00062,000129,000160,000374,000442,000752,000849,000813,000819,000822,000849,000808,000799,000866,0001,230,0001,175,000998,000530,000884,000909,000731,000671,000613,000496,000531,000493,000795,000804,000819,000777,000796,000864,000839,000795,000823,000799,0001,555,0003,637,0004,248,000924,000679,0001,199,0001,482,0001,517,0001,964,0002,030,0001,508,00040,00042,00049,000388,00055,00058,00055,00091,000102,000360,000849,000581,000413,0001,020,000657,0006,058,0001,242,000398,0001,624,0004,091,0003,167,0002,573,0002,573,0003,218,0000003,962,0000004,456,9350003,430,8160002,857,59501,249,0000273,882000704,2250001,226,153000971,939000292,357000199,692000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-4,940,559
0
0
0
2,676
0
0
0
0
0
0
0
4,456,503
0
0
0
3,319,000
0
0
0
3,743,000
1,407,000
0
0
1,534,000
0
0
0
4,961,000
5,561,000
0
6,926,000
6,926,000
6,238,000
8,204,000
6,492,000
8,919,000
7,090,000
9,809,000
7,181,000
0
0
9,985,000
0
-24,000
0
0
11,183,000
-725,000
10,782,000
0
0
8,754,000
8,542,000
0
0
-301,000
7,520,000
7,268,000
7,294,000
5,514,000
8,579,000
7,817,000
6,809,000
4,762,000
6,704,000
6,615,000
5,876,000
4,633,000
5,866,000
5,619,000
5,449,000
4,998,998
4,686,000
4,348,000
4,540,000
2,802,000
5,444,000
5,257,000
5,509,000
2,995,000
5,289,000
5,319,000
5,506,998
5,181,003
5,080,000
5,024,000
5,668,000
5,650,997
6,281,000
6,356,000
8,846,448
8,777,792
9,026,974
8,908,000
10,058,296
9,976,620
10,769,493
11,092,000
11,988,645
8,407,000
11,072,000
12,623,997
11,879,000
13,080,408
14,823,608
14,168,000
14,168,00014,823,60813,080,40811,879,00012,623,99711,072,0008,407,00011,988,64511,092,00010,769,4939,976,62010,058,2968,908,0009,026,9748,777,7928,846,4486,356,0006,281,0005,650,9975,668,0005,024,0005,080,0005,181,0035,506,9985,319,0005,289,0002,995,0005,509,0005,257,0005,444,0002,802,0004,540,0004,348,0004,686,0004,998,9985,449,0005,619,0005,866,0004,633,0005,876,0006,615,0006,704,0004,762,0006,809,0007,817,0008,579,0005,514,0007,294,0007,268,0007,520,000-301,000008,542,0008,754,0000010,782,000-725,00011,183,00000-24,00009,985,000007,181,0009,809,0007,090,0008,919,0006,492,0008,204,0006,238,0006,926,0006,926,00005,561,0004,961,0000001,534,000001,407,0003,743,0000003,319,0000004,456,50300000002,676000-4,940,55900000000000000000000000
       Other Current Assets 
0
0
0
81,356
0
0
0
81,297
0
2,583,100
0
108,165
0
0
0
109,600
0
0
0
140,514
0
4,384,000
0
3,963,000
0
4,587,000
4,675,000
4,470,000
10,501,453
4,930,639
0
358,466
11,446,786
4,428,482
0
4,139,000
11,772,225
4,674,498
0
1,526,000
12,950,313
5,494,267
12,996,000
2,217,000
7,941,000
4,701,000
4,986,000
4,740,000
4,961,000
4,926,000
4,960,000
1,624,000
6,926,000
5,744,000
6,055,000
7,002,000
1,338,000
8,204,000
2,111,000
9,005,000
2,218,000
9,809,000
2,710,000
9,842,000
9,660,000
38,000
10,808,000
10,608,000
11,171,000
10,635,000
49,000
11,624,000
7,000
10,378,000
9,728,000
1,624,000
1,009,000
8,542,000
9,123,000
8,764,000
756,000
946,000
1,106,000
3,634,000
644,000
361,000
356,000
3,595,000
334,000
501,000
553,000
2,845,000
460,000
633,000
998,000
2,424,000
640,000
812,000
721,000
2,759,000
584,000
297,000
344,000
4,026,000
352,000
456,000
332,000
2,567,000
454,000
229,000
369,000
3,679,000
411,000
527,000
756,000
4,832,000
517,000
902,000
1,288,000
4,438,000
548,000
884,000
794,000
5,363,000
1,164,000
1,603,000
1,684,000
1,810,081
48,445
1,196,000
1,196,00048,4451,810,0811,684,0001,603,0001,164,0005,363,000794,000884,000548,0004,438,0001,288,000902,000517,0004,832,000756,000527,000411,0003,679,000369,000229,000454,0002,567,000332,000456,000352,0004,026,000344,000297,000584,0002,759,000721,000812,000640,0002,424,000998,000633,000460,0002,845,000553,000501,000334,0003,595,000356,000361,000644,0003,634,0001,106,000946,000756,0008,764,0009,123,0008,542,0001,009,0001,624,0009,728,00010,378,0007,00011,624,00049,00010,635,00011,171,00010,608,00010,808,00038,0009,660,0009,842,0002,710,0009,809,0002,218,0009,005,0002,111,0008,204,0001,338,0007,002,0006,055,0005,744,0006,926,0001,624,0004,960,0004,926,0004,961,0004,740,0004,986,0004,701,0007,941,0002,217,00012,996,0005,494,26712,950,3131,526,00004,674,49811,772,2254,139,00004,428,48211,446,786358,46604,930,63910,501,4534,470,0004,675,0004,587,00003,963,00004,384,0000140,514000109,600000108,16502,583,100081,29700081,356000
   > Long-term Assets 
0
0
0
2,529,436
0
0
0
2,770,352
0
2,984,900
0
3,005,439
0
0
0
3,365,072
0
0
0
3,560,801
0
4,202,000
0
4,516,557
0
9,873,000
10,117,000
9,897,132
7,908,797
9,706,258
9,264,032
7,925,081
7,625,210
7,658,171
7,945,243
11,624,534
8,217,722
8,899,448
9,003,173
9,450,000
9,581,768
9,942,629
10,058,000
10,640,000
10,524,000
12,432,000
12,218,000
11,176,000
11,070,000
11,446,000
11,432,000
11,070,000
12,996,000
13,408,000
13,689,000
12,996,000
13,279,000
31,522,000
31,259,000
30,875,000
34,006,000
33,726,000
32,634,000
30,632,000
30,663,000
31,074,000
31,359,000
31,160,000
31,728,000
31,271,000
31,821,000
30,996,000
31,067,000
30,715,000
30,109,000
29,324,000
29,203,000
31,613,000
34,419,000
34,486,000
33,985,000
34,593,000
35,329,000
35,564,000
42,848,000
42,335,000
41,092,000
41,898,000
41,010,000
41,357,000
40,919,000
44,117,000
51,554,000
51,099,000
50,356,000
49,264,000
49,322,000
50,821,000
50,953,000
50,204,000
50,099,000
48,895,000
48,335,000
45,060,000
47,406,000
46,670,000
45,386,000
45,814,000
44,389,000
44,999,000
45,946,000
47,185,000
46,191,000
46,367,000
80,530,000
79,119,000
77,626,000
75,662,000
73,961,000
73,890,000
74,421,000
73,704,000
73,585,000
75,957,597
76,641,320
78,959,491
80,767,000
78,208,000
80,114,000
83,483,000
83,483,00080,114,00078,208,00080,767,00078,959,49176,641,32075,957,59773,585,00073,704,00074,421,00073,890,00073,961,00075,662,00077,626,00079,119,00080,530,00046,367,00046,191,00047,185,00045,946,00044,999,00044,389,00045,814,00045,386,00046,670,00047,406,00045,060,00048,335,00048,895,00050,099,00050,204,00050,953,00050,821,00049,322,00049,264,00050,356,00051,099,00051,554,00044,117,00040,919,00041,357,00041,010,00041,898,00041,092,00042,335,00042,848,00035,564,00035,329,00034,593,00033,985,00034,486,00034,419,00031,613,00029,203,00029,324,00030,109,00030,715,00031,067,00030,996,00031,821,00031,271,00031,728,00031,160,00031,359,00031,074,00030,663,00030,632,00032,634,00033,726,00034,006,00030,875,00031,259,00031,522,00013,279,00012,996,00013,689,00013,408,00012,996,00011,070,00011,432,00011,446,00011,070,00011,176,00012,218,00012,432,00010,524,00010,640,00010,058,0009,942,6299,581,7689,450,0009,003,1738,899,4488,217,72211,624,5347,945,2437,658,1717,625,2107,925,0819,264,0329,706,2587,908,7979,897,13210,117,0009,873,00004,516,55704,202,00003,560,8010003,365,0720003,005,43902,984,90002,770,3520002,529,436000
       Property Plant Equipment 
0
0
0
2,490,977
0
0
0
2,709,379
0
2,917,900
0
2,915,817
0
0
0
3,120,184
0
0
0
3,225,220
0
3,528,000
0
3,636,816
0
5,689,000
5,994,000
5,978,061
7,908,797
6,015,780
9,264,032
4,961,764
7,625,210
4,961,391
7,945,243
7,729,641
8,217,722
6,113,656
9,003,173
6,597,000
9,581,768
7,024,520
10,058,000
7,536,000
7,556,000
7,537,000
9,177,000
8,083,000
6,985,000
7,355,000
7,262,000
6,985,000
7,453,000
7,269,000
7,297,000
7,453,000
7,420,000
8,161,000
8,316,000
8,298,000
8,486,000
8,479,000
7,830,000
7,043,000
6,820,000
7,262,000
7,363,000
7,307,000
7,067,000
6,824,000
7,096,000
6,957,000
7,062,000
6,832,000
6,526,000
6,425,000
6,335,000
6,047,000
6,094,000
6,089,000
5,882,000
5,665,000
5,728,000
5,818,000
6,173,000
6,150,000
5,989,000
6,010,000
5,913,000
6,134,000
6,205,000
6,413,000
6,560,000
6,613,000
6,690,000
6,848,000
6,954,000
7,079,000
7,329,000
7,615,000
7,721,000
7,514,000
7,591,000
7,421,000
8,153,000
8,144,000
8,007,000
8,335,000
7,991,000
8,109,000
8,360,000
8,917,000
8,849,000
9,031,000
10,162,000
10,171,000
10,015,000
9,627,000
9,227,000
9,449,000
9,599,000
9,624,000
9,700,000
10,487,171
10,608,016
10,834,714
11,513,000
11,634,910
12,303,000
13,229,000
13,229,00012,303,00011,634,91011,513,00010,834,71410,608,01610,487,1719,700,0009,624,0009,599,0009,449,0009,227,0009,627,00010,015,00010,171,00010,162,0009,031,0008,849,0008,917,0008,360,0008,109,0007,991,0008,335,0008,007,0008,144,0008,153,0007,421,0007,591,0007,514,0007,721,0007,615,0007,329,0007,079,0006,954,0006,848,0006,690,0006,613,0006,560,0006,413,0006,205,0006,134,0005,913,0006,010,0005,989,0006,150,0006,173,0005,818,0005,728,0005,665,0005,882,0006,089,0006,094,0006,047,0006,335,0006,425,0006,526,0006,832,0007,062,0006,957,0007,096,0006,824,0007,067,0007,307,0007,363,0007,262,0006,820,0007,043,0007,830,0008,479,0008,486,0008,298,0008,316,0008,161,0007,420,0007,453,0007,297,0007,269,0007,453,0006,985,0007,262,0007,355,0006,985,0008,083,0009,177,0007,537,0007,556,0007,536,00010,058,0007,024,5209,581,7686,597,0009,003,1736,113,6568,217,7227,729,6417,945,2434,961,3917,625,2104,961,7649,264,0326,015,7807,908,7975,978,0615,994,0005,689,00003,636,81603,528,00003,225,2200003,120,1840002,915,81702,917,90002,709,3790002,490,977000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,680,662
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,097,000
1,097,000
1,102,000
9,698,000
9,713,000
9,884,000
9,906,000
9,903,000
9,870,000
9,874,000
9,855,000
9,887,000
9,893,000
9,889,000
9,866,000
9,846,000
9,878,000
9,871,000
9,890,000
9,877,000
9,874,000
9,862,000
9,871,000
9,887,000
9,898,000
9,898,000
9,881,000
9,958,000
9,943,000
9,981,000
11,601,000
11,560,000
11,368,000
11,550,000
11,387,000
11,467,000
11,430,000
11,868,000
11,988,000
11,848,000
11,806,000
11,658,000
11,688,000
11,774,000
11,841,000
11,825,000
11,834,000
11,717,000
11,729,000
11,707,000
11,674,000
11,668,000
11,595,000
11,668,000
11,569,000
11,645,000
11,711,000
11,845,000
11,765,000
11,798,000
20,081,000
19,997,000
19,963,000
19,821,000
19,707,000
19,820,000
20,001,000
19,960,000
19,939,000
20,019,693
19,962,976
21,060,000
21,139,000
21,025,000
21,142,278
21,222,000
21,222,00021,142,27821,025,00021,139,00021,060,00019,962,97620,019,69319,939,00019,960,00020,001,00019,820,00019,707,00019,821,00019,963,00019,997,00020,081,00011,798,00011,765,00011,845,00011,711,00011,645,00011,569,00011,668,00011,595,00011,668,00011,674,00011,707,00011,729,00011,717,00011,834,00011,825,00011,841,00011,774,00011,688,00011,658,00011,806,00011,848,00011,988,00011,868,00011,430,00011,467,00011,387,00011,550,00011,368,00011,560,00011,601,0009,981,0009,943,0009,958,0009,881,0009,898,0009,898,0009,887,0009,871,0009,862,0009,874,0009,877,0009,890,0009,871,0009,878,0009,846,0009,866,0009,889,0009,893,0009,887,0009,855,0009,874,0009,870,0009,903,0009,906,0009,884,0009,713,0009,698,0001,102,0001,097,0001,097,000000000000000000000002,680,662000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
827,000
1,075,000
846,834
1,089,000
1,174,000
914,697
1,234,000
978,000
1,606,000
1,435,000
1,336,000
1,512,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000001,512,0001,336,0001,435,0001,606,000978,0001,234,000914,6971,174,0001,089,000846,8341,075,000827,000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
27,814
0
0
0
42,813
0
0
0
133,902
0
438,000
0
637,397
0
3,959,000
3,897,000
3,734,163
0
3,503,454
0
2,952,862
0
0
0
3,861,709
0
2,763,667
0
2,807,000
0
2,870,978
0
2,884,000
2,910,000
4,762,000
2,907,000
2,826,000
2,712,000
2,696,000
2,763,000
2,712,000
4,204,000
4,609,000
4,710,000
3,107,000
3,345,000
11,723,000
11,682,000
11,467,000
13,778,000
13,638,000
13,223,000
12,323,000
12,040,000
12,098,000
12,230,000
12,226,000
13,040,000
12,832,000
12,945,000
12,158,000
12,232,000
12,072,000
11,661,000
10,980,000
11,027,000
13,609,000
16,677,000
16,448,000
16,051,000
16,391,000
17,256,000
16,047,000
21,532,000
21,150,000
20,351,000
20,981,000
20,319,000
20,486,000
19,997,000
22,646,000
29,627,000
29,438,000
28,507,000
27,586,000
27,386,000
27,465,000
27,124,000
26,188,000
25,850,000
24,887,000
24,418,000
21,959,000
22,852,000
22,257,000
21,454,000
20,833,000
19,718,000
19,728,000
20,613,000
20,947,000
20,347,000
20,006,000
44,104,000
42,387,000
41,265,000
39,900,000
39,585,000
39,307,000
39,291,000
38,326,000
37,687,000
38,089,000
38,834,000
39,426,000
39,394,000
37,177,000
37,571,819
37,925,000
37,925,00037,571,81937,177,00039,394,00039,426,00038,834,00038,089,00037,687,00038,326,00039,291,00039,307,00039,585,00039,900,00041,265,00042,387,00044,104,00020,006,00020,347,00020,947,00020,613,00019,728,00019,718,00020,833,00021,454,00022,257,00022,852,00021,959,00024,418,00024,887,00025,850,00026,188,00027,124,00027,465,00027,386,00027,586,00028,507,00029,438,00029,627,00022,646,00019,997,00020,486,00020,319,00020,981,00020,351,00021,150,00021,532,00016,047,00017,256,00016,391,00016,051,00016,448,00016,677,00013,609,00011,027,00010,980,00011,661,00012,072,00012,232,00012,158,00012,945,00012,832,00013,040,00012,226,00012,230,00012,098,00012,040,00012,323,00013,223,00013,638,00013,778,00011,467,00011,682,00011,723,0003,345,0003,107,0004,710,0004,609,0004,204,0002,712,0002,763,0002,696,0002,712,0002,826,0002,907,0004,762,0002,910,0002,884,00002,870,97802,807,00002,763,66703,861,7090002,952,86203,503,45403,734,1633,897,0003,959,0000637,3970438,0000133,90200042,81300027,81400000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,467,000
3,428,000
2,799,562
3,487,000
3,520,000
2,592,130
3,363,000
2,995,000
3,121,000
3,166,000
2,994,000
3,466,000
3,591,000
3,899,000
4,047,000
4,284,000
4,170,000
4,412,000
4,598,000
5,302,000
5,146,000
5,134,000
4,340,000
4,172,000
4,296,000
4,651,000
4,969,000
0
0
0
0
0
46,551
0
046,551000004,969,0004,651,0004,296,0004,172,0004,340,0005,134,0005,146,0005,302,0004,598,0004,412,0004,170,0004,284,0004,047,0003,899,0003,591,0003,466,0002,994,0003,166,0003,121,0002,995,0003,363,0002,592,1303,520,0003,487,0002,799,5623,428,0002,467,000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
0
0
0
5,100,290
0
0
0
4,593,280
0
4,719,700
0
4,833,426
0
0
0
4,901,188
0
0
0
4,658,467
0
4,801,000
0
4,753,921
0
8,434,000
8,627,000
9,469,340
8,880,544
9,279,203
9,603,410
8,897,419
9,543,972
8,895,244
9,113,631
12,682,252
9,495,701
9,211,215
8,983,217
10,350,000
10,358,046
9,415,161
9,489,000
10,316,000
11,370,000
11,540,000
9,552,000
11,097,000
11,149,000
11,314,000
11,158,000
11,149,000
14,516,000
13,450,000
13,339,000
14,516,000
15,543,000
32,633,000
31,208,000
33,042,000
33,591,000
34,107,000
31,972,000
30,724,000
30,986,000
32,258,000
32,346,000
34,099,000
33,187,000
32,382,000
34,078,000
32,717,000
31,987,000
29,591,000
28,422,000
29,358,000
29,042,000
29,150,000
30,187,000
29,582,000
29,841,000
30,575,000
30,674,000
32,646,000
37,913,000
36,487,000
35,698,000
38,949,000
36,745,000
36,870,000
36,750,000
41,615,000
47,681,000
49,029,000
48,310,000
45,857,000
46,180,000
49,707,000
49,140,000
46,712,000
48,708,000
47,072,000
47,906,000
46,607,000
49,026,000
46,818,000
45,237,000
46,781,000
44,995,000
46,271,000
50,494,000
51,091,000
50,480,000
57,948,000
67,309,000
66,076,000
63,914,000
60,628,000
59,031,000
59,425,000
60,876,000
59,127,000
58,865,000
61,865,523
64,743,275
64,752,243
64,117,000
63,164,000
65,159,840
67,612,000
67,612,00065,159,84063,164,00064,117,00064,752,24364,743,27561,865,52358,865,00059,127,00060,876,00059,425,00059,031,00060,628,00063,914,00066,076,00067,309,00057,948,00050,480,00051,091,00050,494,00046,271,00044,995,00046,781,00045,237,00046,818,00049,026,00046,607,00047,906,00047,072,00048,708,00046,712,00049,140,00049,707,00046,180,00045,857,00048,310,00049,029,00047,681,00041,615,00036,750,00036,870,00036,745,00038,949,00035,698,00036,487,00037,913,00032,646,00030,674,00030,575,00029,841,00029,582,00030,187,00029,150,00029,042,00029,358,00028,422,00029,591,00031,987,00032,717,00034,078,00032,382,00033,187,00034,099,00032,346,00032,258,00030,986,00030,724,00031,972,00034,107,00033,591,00033,042,00031,208,00032,633,00015,543,00014,516,00013,339,00013,450,00014,516,00011,149,00011,158,00011,314,00011,149,00011,097,0009,552,00011,540,00011,370,00010,316,0009,489,0009,415,16110,358,04610,350,0008,983,2179,211,2159,495,70112,682,2529,113,6318,895,2449,543,9728,897,4199,603,4109,279,2038,880,5449,469,3408,627,0008,434,00004,753,92104,801,00004,658,4670004,901,1880004,833,42604,719,70004,593,2800005,100,290000
   > Total Current Liabilities 
0
0
0
3,490,918
0
0
0
2,964,214
0
3,085,400
0
3,127,511
0
0
0
3,202,384
0
0
0
3,079,746
0
3,225,000
0
3,324,757
0
5,952,000
6,251,000
7,015,548
6,888,114
6,800,881
7,222,771
6,900,466
6,971,336
6,289,129
6,404,092
9,268,518
7,231,195
7,162,602
6,900,803
8,215,000
8,159,428
7,121,790
7,095,000
7,695,000
7,747,000
6,957,000
6,760,000
7,782,000
6,839,000
6,797,000
6,741,000
6,839,000
9,447,000
8,405,000
8,088,000
9,447,000
10,349,000
24,933,000
15,528,000
15,187,000
15,682,000
15,991,000
14,456,000
13,320,000
14,049,000
15,143,000
15,116,000
17,640,000
16,994,000
16,304,000
16,852,000
16,787,000
16,016,000
13,838,000
14,657,000
15,752,000
15,800,000
14,801,000
14,128,000
13,903,000
13,862,000
15,197,000
14,675,000
16,051,000
17,513,000
16,322,000
15,824,000
17,330,000
15,758,000
16,150,000
16,036,000
14,869,000
15,932,000
14,335,000
15,382,000
15,256,000
15,429,000
15,657,000
14,463,000
16,383,000
18,164,000
17,201,000
15,248,000
16,292,000
18,256,000
16,034,000
14,776,000
18,117,000
17,043,000
18,183,000
18,942,000
20,307,000
21,513,000
22,222,000
23,649,000
22,594,000
22,740,000
21,815,000
24,850,000
26,293,000
24,860,000
26,375,000
28,588,000
30,498,875
28,879,266
28,570,520
25,926,000
27,866,000
29,145,926
33,536,000
33,536,00029,145,92627,866,00025,926,00028,570,52028,879,26630,498,87528,588,00026,375,00024,860,00026,293,00024,850,00021,815,00022,740,00022,594,00023,649,00022,222,00021,513,00020,307,00018,942,00018,183,00017,043,00018,117,00014,776,00016,034,00018,256,00016,292,00015,248,00017,201,00018,164,00016,383,00014,463,00015,657,00015,429,00015,256,00015,382,00014,335,00015,932,00014,869,00016,036,00016,150,00015,758,00017,330,00015,824,00016,322,00017,513,00016,051,00014,675,00015,197,00013,862,00013,903,00014,128,00014,801,00015,800,00015,752,00014,657,00013,838,00016,016,00016,787,00016,852,00016,304,00016,994,00017,640,00015,116,00015,143,00014,049,00013,320,00014,456,00015,991,00015,682,00015,187,00015,528,00024,933,00010,349,0009,447,0008,088,0008,405,0009,447,0006,839,0006,741,0006,797,0006,839,0007,782,0006,760,0006,957,0007,747,0007,695,0007,095,0007,121,7908,159,4288,215,0006,900,8037,162,6027,231,1959,268,5186,404,0926,289,1296,971,3366,900,4667,222,7716,800,8816,888,1147,015,5486,251,0005,952,00003,324,75703,225,00003,079,7460003,202,3840003,127,51103,085,40002,964,2140003,490,918000
       Short-term Debt 
0
0
0
1,013,254
0
0
0
347,076
0
478,400
0
418,753
0
0
0
397,301
0
0
0
309,132
0
496,000
0
278,861
0
678,000
382,000
378,815
0
444,058
0
213,586
0
264,943
0
460,419
0
478,714
0
516,000
0
55,153
0
152,000
72,000
102,000
170,000
142,000
90,000
150,000
122,000
90,000
136,000
85,000
113,000
136,000
59,000
14,342,000
5,403,000
4,280,000
3,886,000
3,841,000
2,546,000
993,000
1,628,000
1,498,000
980,000
1,926,000
1,277,000
1,275,000
1,376,000
125,000
435,000
372,000
2,055,000
1,990,000
2,006,000
2,008,000
1,566,000
901,000
889,000
1,880,000
1,710,000
1,790,000
2,795,000
2,512,000
2,416,000
2,467,000
2,316,000
2,711,000
2,696,000
925,000
2,172,000
1,117,000
2,951,000
2,325,000
2,840,000
2,939,000
951,000
2,271,000
4,210,000
4,238,000
2,524,000
1,781,000
3,747,000
1,846,000
603,000
2,046,000
2,501,000
4,167,000
3,594,000
2,419,000
3,148,000
3,800,000
3,931,000
2,892,000
3,153,000
3,310,000
6,538,000
6,502,000
4,693,000
5,675,000
6,509,000
6,389,000
6,423,000
5,410,000
1,570,000
2,495,000
3,780,000
6,853,000
6,853,0003,780,0002,495,0001,570,0005,410,0006,423,0006,389,0006,509,0005,675,0004,693,0006,502,0006,538,0003,310,0003,153,0002,892,0003,931,0003,800,0003,148,0002,419,0003,594,0004,167,0002,501,0002,046,000603,0001,846,0003,747,0001,781,0002,524,0004,238,0004,210,0002,271,000951,0002,939,0002,840,0002,325,0002,951,0001,117,0002,172,000925,0002,696,0002,711,0002,316,0002,467,0002,416,0002,512,0002,795,0001,790,0001,710,0001,880,000889,000901,0001,566,0002,008,0002,006,0001,990,0002,055,000372,000435,000125,0001,376,0001,275,0001,277,0001,926,000980,0001,498,0001,628,000993,0002,546,0003,841,0003,886,0004,280,0005,403,00014,342,00059,000136,000113,00085,000136,00090,000122,000150,00090,000142,000170,000102,00072,000152,000055,1530516,0000478,7140460,4190264,9430213,5860444,0580378,815382,000678,0000278,8610496,0000309,132000397,301000418,7530478,4000347,0760001,013,254000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17,510,000
19,734,000
7,827
1,421,000
1,434,000
1,042,431
1,432,000
1,026,000
3,544,000
1,629,000
228,000
1,822,000
2,289,000
3,958,000
3,402,000
2,194,000
2,042,000
2,696,000
2,744,000
1,660,000
2,069,000
2,162,000
5,408,000
5,314,000
3,625,000
4,556,000
5,372,000
5,129,000
6,050,000
5,067,000
1,253,000
2,156,000
3,051,000
6,492,000
6,492,0003,051,0002,156,0001,253,0005,067,0006,050,0005,129,0005,372,0004,556,0003,625,0005,314,0005,408,0002,162,0002,069,0001,660,0002,744,0002,696,0002,042,0002,194,0003,402,0003,958,0002,289,0001,822,000228,0001,629,0003,544,0001,026,0001,432,0001,042,4311,434,0001,421,0007,82719,734,00017,510,000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
625,703
0
0
0
791,082
0
2,564,000
0
822,053
0
0
0
820,290
0
0
0
874,496
0
2,724,000
0
976,015
0
0
0
1,614,000
0
0
7,222,771
3,005,138
0
0
6,404,092
2,385,000
0
0
6,900,803
3,171,000
0
0
0
3,086,000
7,675,000
6,590,000
6,590,000
3,125,000
5,466,000
5,496,000
5,404,000
5,466,000
6,334,000
6,572,000
5,780,000
3,482,000
6,913,000
7,025,000
6,632,000
3,497,000
7,194,000
7,409,000
6,939,000
7,178,000
7,150,000
7,366,000
7,385,000
2,658,000
8,507,000
7,362,000
7,796,000
2,257,000
8,672,000
8,513,000
8,028,000
8,975,000
8,945,000
8,972,000
8,629,000
2,449,000
9,465,000
9,642,000
9,242,000
2,499,000
10,626,000
10,304,000
10,149,000
3,492,000
10,510,000
10,659,000
10,593,000
3,469,000
11,174,000
10,259,000
9,961,000
1,680,000
9,899,000
10,072,000
10,832,000
2,285,000
11,481,000
10,913,000
10,992,000
1,720,000
13,102,000
12,637,000
12,538,000
1,774,000
12,633,000
12,028,000
13,406,000
2,350,000
15,502,000
16,060,000
16,772,000
2,824,000
15,916,000
16,002,000
15,749,000
2,550,000
17,215,000
17,733,000
18,560,000
3,267,000
19,699,000
20,463,000
21,684,000
22,465,000
22,557,099
23,986,000
23,986,00022,557,09922,465,00021,684,00020,463,00019,699,0003,267,00018,560,00017,733,00017,215,0002,550,00015,749,00016,002,00015,916,0002,824,00016,772,00016,060,00015,502,0002,350,00013,406,00012,028,00012,633,0001,774,00012,538,00012,637,00013,102,0001,720,00010,992,00010,913,00011,481,0002,285,00010,832,00010,072,0009,899,0001,680,0009,961,00010,259,00011,174,0003,469,00010,593,00010,659,00010,510,0003,492,00010,149,00010,304,00010,626,0002,499,0009,242,0009,642,0009,465,0002,449,0008,629,0008,972,0008,945,0008,975,0008,028,0008,513,0008,672,0002,257,0007,796,0007,362,0008,507,0002,658,0007,385,0007,366,0007,150,0007,178,0006,939,0007,409,0007,194,0003,497,0006,632,0007,025,0006,913,0003,482,0005,780,0006,572,0006,334,0005,466,0005,404,0005,496,0005,466,0003,125,0006,590,0006,590,0007,675,0003,086,0000003,171,0006,900,803002,385,0006,404,092003,005,1387,222,771001,614,000000976,01502,724,0000874,496000820,290000822,05302,564,0000791,082000625,703000
       Other Current Liabilities 
0
0
0
1,584,226
0
0
0
1,500,868
0
43,000
0
1,543,668
0
0
0
1,549,817
0
0
0
1,482,841
0
5,000
0
3,932,015
0
5,274,000
5,869,000
4,386,502
6,888,114
6,356,824
0
2,790,059
6,971,336
6,024,186
0
4,967,181
7,231,195
6,683,888
0
3,673,000
8,159,428
7,066,637
7,095,000
3,468,000
6,855,000
6,855,000
0
3,318,000
1,283,000
1,151,000
1,283,000
1,283,000
2,977,000
1,748,000
4,624,000
4,624,000
99,000
154,000
100,000
5,238,000
531,000
484,000
435,000
5,149,000
604,000
1,022,000
1,160,000
7,328,000
1,176,000
1,148,000
966,000
7,507,000
1,151,000
1,293,000
1,083,000
1,397,000
1,683,000
1,083,000
1,006,000
7,691,000
690,000
684,000
579,000
8,686,000
776,000
679,000
564,000
9,017,000
602,000
731,000
682,000
8,992,000
790,000
999,000
936,000
9,871,000
1,044,000
1,070,000
1,167,000
10,477,000
1,011,000
777,000
508,000
11,627,000
397,000
410,000
401,000
12,936,000
649,000
612,000
621,000
14,411,000
1,869,000
1,582,000
1,959,000
15,962,000
2,547,000
1,522,000
1,470,000
16,345,000
1,749,000
1,767,000
2,356,000
19,304,237
1,127,492
1,172,278
1,204,000
1,500,000
2,808,827
1,268,000
1,268,0002,808,8271,500,0001,204,0001,172,2781,127,49219,304,2372,356,0001,767,0001,749,00016,345,0001,470,0001,522,0002,547,00015,962,0001,959,0001,582,0001,869,00014,411,000621,000612,000649,00012,936,000401,000410,000397,00011,627,000508,000777,0001,011,00010,477,0001,167,0001,070,0001,044,0009,871,000936,000999,000790,0008,992,000682,000731,000602,0009,017,000564,000679,000776,0008,686,000579,000684,000690,0007,691,0001,006,0001,083,0001,683,0001,397,0001,083,0001,293,0001,151,0007,507,000966,0001,148,0001,176,0007,328,0001,160,0001,022,000604,0005,149,000435,000484,000531,0005,238,000100,000154,00099,0004,624,0004,624,0001,748,0002,977,0001,283,0001,283,0001,151,0001,283,0003,318,00006,855,0006,855,0003,468,0007,095,0007,066,6378,159,4283,673,00006,683,8887,231,1954,967,18106,024,1866,971,3362,790,05906,356,8246,888,1144,386,5025,869,0005,274,00003,932,01505,00001,482,8410001,549,8170001,543,668043,00001,500,8680001,584,226000
   > Long-term Liabilities 
0
0
0
1,609,372
0
0
0
1,629,067
0
1,634,300
0
1,705,915
0
0
0
1,698,805
0
0
0
1,578,721
0
1,576,000
0
1,429,164
0
2,482,000
2,376,000
2,453,792
1,992,430
2,478,321
2,380,640
1,996,953
2,572,636
2,606,115
2,709,539
3,413,735
2,264,506
2,048,613
2,082,414
2,135,000
2,198,618
2,293,372
2,394,000
2,621,000
3,623,000
4,583,000
2,792,000
3,315,000
4,310,000
4,517,000
4,417,000
4,310,000
5,069,000
5,045,000
5,251,000
5,069,000
5,194,000
7,700,000
15,680,000
17,855,000
17,909,000
18,116,000
17,516,000
17,404,000
16,937,000
17,115,000
17,230,000
16,459,000
16,193,000
16,078,000
17,226,000
15,930,000
15,971,000
15,753,000
13,765,000
13,606,000
13,242,000
14,349,000
16,059,000
15,679,000
15,979,000
15,378,000
15,999,000
16,595,000
20,400,000
20,165,000
19,874,000
21,619,000
20,987,000
20,720,000
20,714,000
26,746,000
31,749,000
34,694,000
32,928,000
30,601,000
30,751,000
34,050,000
34,677,000
30,329,000
30,544,000
29,871,000
32,658,000
30,315,000
30,770,000
30,784,000
30,461,000
28,664,000
27,952,000
28,088,000
31,552,000
30,784,000
28,967,000
35,726,000
43,660,000
43,482,000
41,174,000
38,813,000
34,181,000
33,132,000
36,016,000
32,752,000
30,277,000
31,366,648
35,864,009
36,181,724
38,191,000
35,298,000
36,013,914
34,076,000
34,076,00036,013,91435,298,00038,191,00036,181,72435,864,00931,366,64830,277,00032,752,00036,016,00033,132,00034,181,00038,813,00041,174,00043,482,00043,660,00035,726,00028,967,00030,784,00031,552,00028,088,00027,952,00028,664,00030,461,00030,784,00030,770,00030,315,00032,658,00029,871,00030,544,00030,329,00034,677,00034,050,00030,751,00030,601,00032,928,00034,694,00031,749,00026,746,00020,714,00020,720,00020,987,00021,619,00019,874,00020,165,00020,400,00016,595,00015,999,00015,378,00015,979,00015,679,00016,059,00014,349,00013,242,00013,606,00013,765,00015,753,00015,971,00015,930,00017,226,00016,078,00016,193,00016,459,00017,230,00017,115,00016,937,00017,404,00017,516,00018,116,00017,909,00017,855,00015,680,0007,700,0005,194,0005,069,0005,251,0005,045,0005,069,0004,310,0004,417,0004,517,0004,310,0003,315,0002,792,0004,583,0003,623,0002,621,0002,394,0002,293,3722,198,6182,135,0002,082,4142,048,6132,264,5063,413,7352,709,5392,606,1152,572,6361,996,9532,380,6402,478,3211,992,4302,453,7922,376,0002,482,00001,429,16401,576,00001,578,7210001,698,8050001,705,91501,634,30001,629,0670001,609,372000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,081,000
17,255,000
13,902,324
14,765,000
14,850,000
10,582,147
14,234,000
11,114,000
11,062,000
10,856,000
10,753,000
10,283,000
9,476,000
10,133,000
10,527,000
10,491,000
9,630,000
9,636,000
13,203,000
13,011,000
11,582,000
10,735,000
9,444,000
8,499,000
8,237,000
7,701,000
7,233,000
0
0
0
0
0
0
0
00000007,233,0007,701,0008,237,0008,499,0009,444,00010,735,00011,582,00013,011,00013,203,0009,636,0009,630,00010,491,00010,527,00010,133,0009,476,00010,283,00010,753,00010,856,00011,062,00011,114,00014,234,00010,582,14714,850,00014,765,00013,902,32417,255,00016,081,000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
2,217,324
0
0
0
2,634,335
0
2,951,400
0
2,875,641
0
0
0
3,483,235
0
0
0
3,570,720
0
4,064,000
0
4,172,960
0
11,145,000
11,889,000
10,296,939
9,529,706
10,637,378
10,806,207
9,527,721
9,528,024
9,497,663
9,991,426
13,710,935
10,494,247
11,056,676
11,551,561
11,172,000
12,174,035
12,731,379
13,565,000
13,178,000
12,319,000
12,707,000
13,332,000
14,418,000
13,597,000
13,477,000
13,275,000
13,597,000
15,304,000
14,910,000
14,683,000
15,304,000
13,907,000
14,847,000
14,614,000
14,778,000
14,720,000
15,974,000
16,105,000
15,912,000
15,383,000
17,796,000
19,394,000
20,660,000
20,727,000
22,091,000
22,125,000
23,213,000
22,349,000
23,606,000
23,931,000
23,246,000
21,516,000
22,026,000
22,038,000
23,737,000
22,292,000
23,216,000
23,248,000
23,224,000
21,454,000
22,029,000
20,445,000
19,627,000
16,936,000
18,279,000
17,349,000
18,490,000
14,741,000
13,530,000
13,072,000
14,854,000
12,989,000
13,653,000
13,725,000
14,960,000
12,915,000
12,645,000
11,936,000
12,468,000
10,483,000
13,548,000
12,164,000
13,127,000
10,778,000
12,237,000
12,195,000
15,622,000
14,430,000
15,676,000
39,744,000
39,268,000
36,340,000
35,932,000
35,134,000
37,037,000
35,789,000
37,392,000
37,197,000
39,087,731
37,416,840
39,518,251
40,719,000
40,786,000
41,039,000
44,719,000
44,719,00041,039,00040,786,00040,719,00039,518,25137,416,84039,087,73137,197,00037,392,00035,789,00037,037,00035,134,00035,932,00036,340,00039,268,00039,744,00015,676,00014,430,00015,622,00012,195,00012,237,00010,778,00013,127,00012,164,00013,548,00010,483,00012,468,00011,936,00012,645,00012,915,00014,960,00013,725,00013,653,00012,989,00014,854,00013,072,00013,530,00014,741,00018,490,00017,349,00018,279,00016,936,00019,627,00020,445,00022,029,00021,454,00023,224,00023,248,00023,216,00022,292,00023,737,00022,038,00022,026,00021,516,00023,246,00023,931,00023,606,00022,349,00023,213,00022,125,00022,091,00020,727,00020,660,00019,394,00017,796,00015,383,00015,912,00016,105,00015,974,00014,720,00014,778,00014,614,00014,847,00013,907,00015,304,00014,683,00014,910,00015,304,00013,597,00013,275,00013,477,00013,597,00014,418,00013,332,00012,707,00012,319,00013,178,00013,565,00012,731,37912,174,03511,172,00011,551,56111,056,67610,494,24713,710,9359,991,4269,497,6639,528,0249,527,72110,806,20710,637,3789,529,70610,296,93911,889,00011,145,00004,172,96004,064,00003,570,7200003,483,2350002,875,64102,951,40002,634,3350002,217,324000
   Common Stock
0
0
0
349,092
0
0
0
368,963
0
0
0
366,215
0
0
0
405,864
0
0
0
391,787
0
0
0
395,054
0
0
0
443,782
0
0
0
442,108
0
0
0
624,261
0
0
0
429,000
0
0
0
423,000
420,000
419,000
415,000
411,000
395,000
404,000
399,000
395,000
383,000
392,000
388,000
383,000
378,000
374,000
369,000
364,000
364,000
363,000
362,000
362,000
362,000
362,000
363,000
363,000
362,000
360,000
356,000
352,000
346,000
341,000
332,000
323,000
318,000
315,000
312,000
312,000
313,000
313,000
314,000
315,000
316,000
316,000
316,000
316,000
316,000
316,000
316,000
316,000
316,000
316,000
316,000
316,000
316,000
316,000
316,000
317,000
317,000
317,000
317,000
317,000
317,000
328,000
328,000
328,000
328,000
328,000
328,000
328,000
328,000
328,000
387,000
387,000
387,000
387,000
387,000
387,000
387,000
387,000
387,000
387,452
387,708
388,000
388,000
387,597
388,000
388,000
388,000388,000387,597388,000388,000387,708387,452387,000387,000387,000387,000387,000387,000387,000387,000387,000328,000328,000328,000328,000328,000328,000328,000328,000328,000317,000317,000317,000317,000317,000317,000316,000316,000316,000316,000316,000316,000316,000316,000316,000316,000316,000316,000316,000316,000316,000315,000314,000313,000313,000312,000312,000315,000318,000323,000332,000341,000346,000352,000356,000360,000362,000363,000363,000362,000362,000362,000362,000363,000364,000364,000369,000374,000378,000383,000388,000392,000383,000395,000399,000404,000395,000411,000415,000419,000420,000423,000000429,000000624,261000442,108000443,782000395,054000391,787000405,864000366,215000368,963000349,092000
   Retained Earnings Total Equity0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,966,000
1,973,000
1,964,000
3,748,000
1,967,000
1,973,000
1,991,000
2,511,000
2,039,000
2,033,000
2,035,000
1,664,000
2,028,000
2,030,000
2,031,000
99,000
2,042,000
2,033,000
2,027,000
1,088,000
2,027,000
2,040,000
2,040,000
34,000
2,046,000
2,044,000
2,052,000
-143,000
2,056,000
2,046,000
2,039,000
881,000
8,304,003
2,033,000
2,037,261
1,593,875
2,044,784
2,072,512
2,080,441
1,629,759
2,062,732
2,072,653
2,076,553
1,614,717
2,075,000
2,078,000
1,990,000
0
2,055,193
0
02,055,19301,990,0002,078,0002,075,0001,614,7172,076,5532,072,6532,062,7321,629,7592,080,4412,072,5122,044,7841,593,8752,037,2612,033,0008,304,003881,0002,039,0002,046,0002,056,000-143,0002,052,0002,044,0002,046,00034,0002,040,0002,040,0002,027,0001,088,0002,027,0002,033,0002,042,00099,0002,031,0002,030,0002,028,0001,664,0002,035,0002,033,0002,039,0002,511,0001,991,0001,973,0001,967,0003,748,0001,964,0001,973,0001,966,00000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
674,516
0
0
0
770,758
0
964,700
0
860,684
0
0
0
1,008,665
0
0
0
729,022
0
1,173,000
0
2,952,960
0
10,721,000
9,346,000
1,314,939
9,529,706
10,637,378
10,806,207
2,123,910
9,528,024
9,497,663
9,991,426
6,370,935
10,494,247
11,056,676
11,551,561
2,292,000
12,174,035
12,731,379
13,565,000
2,306,000
2,343,000
2,396,000
2,473,000
2,417,000
2,523,000
2,476,000
2,504,000
2,523,000
3,573,000
3,284,000
3,476,000
3,573,000
3,588,000
3,710,000
3,735,000
3,790,000
3,771,000
3,810,000
3,920,000
3,978,000
3,999,000
3,997,000
4,043,000
4,099,000
4,228,000
4,311,000
4,536,000
4,589,000
4,671,000
4,925,000
4,985,000
5,029,000
5,172,000
5,299,000
5,392,000
5,464,000
5,611,000
5,719,000
3,770,000
3,983,000
4,179,000
4,236,000
4,245,000
4,261,000
4,276,000
4,281,000
4,291,000
4,304,000
4,322,000
4,326,000
4,344,000
4,351,000
4,368,000
4,374,000
4,381,000
4,393,000
4,407,000
4,409,000
4,417,000
4,427,000
4,438,000
7,911,000
7,919,000
7,798,000
7,946,000
7,950,000
7,952,000
7,971,000
7,976,000
7,980,000
35,118,000
35,126,000
35,131,000
35,134,000
35,137,000
35,155,000
35,159,000
35,163,000
35,166,000
35,132,731
35,167,533
35,205,251
35,203,000
37,238,403
35,231,807
37,308,000
37,308,00035,231,80737,238,40335,203,00035,205,25135,167,53335,132,73135,166,00035,163,00035,159,00035,155,00035,137,00035,134,00035,131,00035,126,00035,118,0007,980,0007,976,0007,971,0007,952,0007,950,0007,946,0007,798,0007,919,0007,911,0004,438,0004,427,0004,417,0004,409,0004,407,0004,393,0004,381,0004,374,0004,368,0004,351,0004,344,0004,326,0004,322,0004,304,0004,291,0004,281,0004,276,0004,261,0004,245,0004,236,0004,179,0003,983,0003,770,0005,719,0005,611,0005,464,0005,392,0005,299,0005,172,0005,029,0004,985,0004,925,0004,671,0004,589,0004,536,0004,311,0004,228,0004,099,0004,043,0003,997,0003,999,0003,978,0003,920,0003,810,0003,771,0003,790,0003,735,0003,710,0003,588,0003,573,0003,476,0003,284,0003,573,0002,523,0002,504,0002,476,0002,523,0002,417,0002,473,0002,396,0002,343,0002,306,00013,565,00012,731,37912,174,0352,292,00011,551,56111,056,67610,494,2476,370,9359,991,4269,497,6639,528,0242,123,91010,806,20710,637,3789,529,7061,314,9399,346,00010,721,00002,952,96001,173,0000729,0220001,008,665000860,6840964,7000770,758000674,516000



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

Currency in USD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue54,073,000
Cost of Revenue-10,207,000
Gross Profit43,866,00043,866,000
 
Operating Income (+$)
Gross Profit43,866,000
Operating Expense-33,863,000
Operating Income10,003,00010,003,000
 
Operating Expense (+$)
Research Development13,583,000
Selling General Administrative19,669,000
Selling And Marketing Expenses555,000
Operating Expense33,863,00033,807,000
 
Net Interest Income (+$)
Interest Income458,000
Interest Expense-1,361,922
Other Finance Cost-380,078
Net Interest Income-1,284,000
 
Pretax Income (+$)
Operating Income10,003,000
Net Interest Income-1,284,000
Other Non-Operating Income Expenses0
Income Before Tax (EBT)8,691,00011,315,000
EBIT - interestExpense = 9,011,078
8,685,000
8,396,922
Interest Expense1,361,922
Earnings Before Interest and Taxes (EBIT)10,373,00010,052,922
Earnings Before Interest and Taxes (EBITDA)15,438,000
 
After tax Income (+$)
Income Before Tax8,691,000
Tax Provision-1,650,000
Net Income From Continuing Ops7,041,0007,041,000
Net Income7,035,000
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses44,070,000
Total Other Income/Expenses Net-1,312,0001,284,000
 

Technical Analysis of Astrazeneca
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Astrazeneca. The general trend of Astrazeneca is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Astrazeneca's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Astrazeneca Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Supportย is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistanceย is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of AstraZeneca PLC.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 164.50 < 164.50 < 171.24.

The bearish price targets are: 152.49 > 142.10 > 141.77.

Know someone who trades $AZNCF? Share this with them.๐Ÿ‘‡

AstraZeneca PLC Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theย moving averageย of the selected period.

  • Moving averages are laggingย trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of AstraZeneca PLC. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

AstraZeneca PLC Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theย momentumย of theย selected period based on two moving averages.

  • MACD is aย lagging momentumย indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of AstraZeneca PLC.

AstraZeneca PLC Daily Moving Average Convergence/Divergence (MACD) ChartAstraZeneca PLC Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of AstraZeneca PLC. The current adx is .

AstraZeneca PLC Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Showsย the current trend.
  • Showsย potential entry signals.
  • Showsย ย potential exit signals.
  • Can be used to placeย trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of AstraZeneca PLC.

AstraZeneca PLC Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumย indicator, meaning the signals are instant.
  • Rangesย between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of AstraZeneca PLC.

AstraZeneca PLC Daily Relative Strength Index (RSI) ChartAstraZeneca PLC Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Comparesย a certain price to multiple prices ranging over time.

  • Leadingย momentumย indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Rangesย between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of AstraZeneca PLC.

AstraZeneca PLC Daily Stochastic Oscillator ChartAstraZeneca PLC Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,ย the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of AstraZeneca PLC.

AstraZeneca PLC Daily Commodity Channel Index (CCI) ChartAstraZeneca PLC Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of AstraZeneca PLC.

AstraZeneca PLC Daily Chande Momentum Oscillator (CMO) ChartAstraZeneca PLC Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

ย Shows the current price relative to the highest high over the last 14 days.
ย 

  • Lagging momentum indicator
  • Ranging between 0 andย -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of AstraZeneca PLC.

AstraZeneca PLC Daily Williams %R ChartAstraZeneca PLC Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldย 

Score

Let's take a look at the Bollinger Bands of AstraZeneca PLC.

AstraZeneca PLC Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of AstraZeneca PLC.

AstraZeneca PLC Daily Average True Range (ATR) ChartAstraZeneca PLC Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

ย Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of AstraZeneca PLC.

AstraZeneca PLC Daily On-Balance Volume (OBV) ChartAstraZeneca PLC Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of AstraZeneca PLC.

AstraZeneca PLC Daily Money Flow Index (MFI) ChartAstraZeneca PLC Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for AstraZeneca PLC.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-04-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-29ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-04-30CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-01STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-02STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-05-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-05-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-22STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-28STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-06-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-03STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-06-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-09STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-06-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-01STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-02CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-07-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-29STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-30ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-31STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-01MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-08-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-08-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-08-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-15MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-08-18BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-25STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-08-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-09-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-05STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-09-08MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-09-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-09-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-09-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-12STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-09-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

AstraZeneca PLC Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of AstraZeneca PLC based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose155.000
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Astrazeneca with someone you think should read this too:
  • Are you bullish or bearish on Astrazeneca? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Astrazeneca? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about AstraZeneca PLC

I send you an email if I find something interesting about AstraZeneca PLC.


Comments

How you think about this?

Leave a comment

Stay informed about AstraZeneca PLC.

Receive notifications about AstraZeneca PLC in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.